Lua error in package.lua at line 80: module 'strict' not found. Chinese Academy of Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: {{{1}}}), is a COVID-19 vaccine developed by Institute of Medical Biology, Chinese Academy of Medical Sciences.[2][3]
Authorizations
Full authorization Emergency authorization
|
<templatestyles src="Module:Hatnote/styles.css"></templatestyles>
On 9 June 2021, The vaccine has been approved by the Chinese authorities.[1]
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
Use <references />
, or <references group="..." />
External links
|
|
|
|
|
|
|
Institutions
|
Hospitals and
medical clinics |
|
Organizations |
Global |
|
By location |
|
Health
institutes |
|
Pandemic
institutes |
|
Relief funds |
|
|
|
|
|
People
|
Medical
professionals |
|
Researchers |
|
Officials |
|
Others |
|
Deaths |
|
|
|
Data (templates)
|
Global |
|
Africa |
|
Americas |
|
Asia |
|
Europe |
|
Oceania |
|
Others |
|
|
|
|
|
Development |
|
Classes |
|
Administration |
|
Vaccines |
|
Controversy |
|
See also |
|
|
Description |
|
Disease |
|
Treatment |
|
|
Description |
|
Disease |
|
Treatment |
|
|
|
|
|
|
|
|
|
Institutions
|
Hospitals and
medical clinics |
|
Organizations |
Global |
|
By location |
|
Health
institutes |
|
Pandemic
institutes |
|
Relief funds |
|
|
|
|
|
People
|
Medical
professionals |
|
Researchers |
|
Officials |
|
Others |
|
Deaths |
|
|
|
Data (templates)
|
Global |
|
Africa |
|
Americas |
|
Asia |
|
Europe |
|
Oceania |
|
Others |
|
|
|
|
<templatestyles src="Asbox/styles.css"></templatestyles>
<templatestyles src="Asbox/styles.css"></templatestyles>
- ↑ 1.0 1.1 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Clinical trial number NCT04412538 for "Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19" at ClinicalTrials.gov
- ↑ Clinical trial number NCT04659239 for "The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19" at ClinicalTrials.gov